Biography

Joseph Sugie earned his Ph.D. from the University of California, San Diego, and specializes in using advanced technologies for mechanism of action determination. Since 2018, he has been dedicated to accelerating biological research by creating bespoke tools and specialized analysis pipelines. As Chief Technology Officer at Linnaeus Bioscience, Dr. Sugie is pioneering the integration of machine learning and AI to transform bacterial cytological profiling.

Expertise

TB Diagnostics
Public Health

Key Impacts

Drugs

Impact details available upon request.

Source: Conference 2024
The future of AI in TB - Panel discussion

Impact details available upon request.

Source: Conference 2024

Research Summaries